annual EBITDA:
$125.50M-$28.70M(-18.61%)Summary
- As of today (September 16, 2025), EVH annual EBITDA is $125.50 million, with the most recent change of -$28.70 million (-18.61%) on December 31, 2024.
- During the last 3 years, EVH annual EBITDA has risen by +$82.88 million (+194.49%).
- EVH annual EBITDA is now -18.61% below its all-time high of $154.20 million, reached on December 31, 2023.
Performance
EVH EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$27.25M+$254.00K(+0.94%)Summary
- As of today (September 16, 2025), EVH quarterly EBITDA is $27.25 million, with the most recent change of +$254.00 thousand (+0.94%) on June 30, 2025.
- Over the past year, EVH quarterly EBITDA has dropped by -$13.19 million (-32.61%).
- EVH quarterly EBITDA is now -35.23% below its all-time high of $42.08 million, reached on March 31, 2023.
Performance
EVH quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$101.59M-$13.19M(-11.49%)Summary
- As of today (September 16, 2025), EVH TTM EBITDA is $101.59 million, with the most recent change of -$13.19 million (-11.49%) on June 30, 2025.
- Over the past year, EVH TTM EBITDA has dropped by -$52.45 million (-34.05%).
- EVH TTM EBITDA is now -37.37% below its all-time high of $162.20 million, reached on December 31, 2023.
Performance
EVH TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
EVH EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -18.6% | -32.6% | -34.0% |
3 y3 years | +194.5% | +85.4% | +63.5% |
5 y5 years | +445.0% | +154.5% | +368.9% |
EVH EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -18.6% | +194.5% | -35.2% | +85.4% | -37.4% | +63.5% |
5 y | 5-year | -18.6% | +445.0% | -35.2% | +240.3% | -37.4% | +368.9% |
alltime | all time | -18.6% | +314.6% | -35.2% | +192.5% | -37.4% | +272.7% |
EVH EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $27.25M(+0.9%) | $101.59M(-11.5%) |
Mar 2025 | - | $27.00M(-9.7%) | $114.78M(-6.8%) |
Dec 2024 | $125.50M(-18.6%) | $29.91M(+71.5%) | $123.11M(-5.8%) |
Sep 2024 | - | $17.43M(-56.9%) | $130.65M(-15.2%) |
Jun 2024 | - | $40.44M(+14.5%) | $154.04M(-0.9%) |
Mar 2024 | - | $35.33M(-5.6%) | $155.45M(-4.2%) |
Dec 2023 | $154.20M(+61.8%) | $37.45M(-8.3%) | $162.20M(+8.5%) |
Sep 2023 | - | $40.83M(-2.5%) | $149.45M(+13.9%) |
Jun 2023 | - | $41.85M(-0.5%) | $131.24M(+26.1%) |
Mar 2023 | - | $42.08M(+70.4%) | $104.09M(+28.7%) |
Dec 2022 | $95.31M(+123.6%) | $24.69M(+9.2%) | $80.89M(+7.1%) |
Sep 2022 | - | $22.62M(+53.9%) | $75.50M(+21.5%) |
Jun 2022 | - | $14.70M(-22.1%) | $62.14M(+2.4%) |
Mar 2022 | - | $18.88M(-2.2%) | $60.68M(+19.2%) |
Dec 2021 | $42.62M(+41.9%) | $19.30M(+108.4%) | $50.93M(+6.8%) |
Sep 2021 | - | $9.26M(-30.1%) | $47.67M(+2.7%) |
Jun 2021 | - | $13.24M(+45.0%) | $46.41M(+5.8%) |
Mar 2021 | - | $9.13M(-43.1%) | $43.88M(+8.9%) |
Dec 2020 | $30.02M(-182.5%) | $16.04M(+100.2%) | $40.30M(+24.7%) |
Sep 2020 | - | $8.01M(-25.2%) | $32.30M(+49.1%) |
Jun 2020 | - | $10.71M(+93.2%) | $21.66M(-972.5%) |
Mar 2020 | - | $5.54M(-31.1%) | -$2.48M(-91.0%) |
Dec 2019 | -$36.37M | $8.05M(-405.9%) | -$27.50M(+61.7%) |
Sep 2019 | - | -$2.63M(-80.4%) | -$17.01M(-770.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2019 | - | -$13.44M(-31.0%) | $2.54M(-92.9%) |
Mar 2019 | - | -$19.48M(-205.0%) | $35.87M(-48.9%) |
Dec 2018 | $68.22M(-383.4%) | $18.55M(+9.6%) | $70.16M(+38.7%) |
Sep 2018 | - | $16.91M(-15.0%) | $50.60M(+70.5%) |
Jun 2018 | - | $19.89M(+34.3%) | $29.69M(-3724.7%) |
Mar 2018 | - | $14.81M(-1558.0%) | -$819.00K(-96.9%) |
Dec 2017 | -$24.07M(-58.8%) | -$1.02M(-74.6%) | -$26.67M(-51.6%) |
Sep 2017 | - | -$4.00M(-62.3%) | -$55.12M(-6.3%) |
Jun 2017 | - | -$10.61M(-3.9%) | -$58.81M(+2.8%) |
Mar 2017 | - | -$11.04M(-62.5%) | -$57.21M(-0.1%) |
Dec 2016 | -$58.48M(+63.3%) | -$29.46M(+283.0%) | -$57.28M(+47.3%) |
Sep 2016 | - | -$7.69M(-14.7%) | -$38.88M(-14.3%) |
Jun 2016 | - | -$9.02M(-18.8%) | -$45.38M(-3.3%) |
Mar 2016 | - | -$11.11M(+0.4%) | -$46.91M(+31.0%) |
Dec 2015 | -$35.81M(<-9900.0%) | -$11.06M(-22.0%) | -$35.81M(+44.7%) |
Sep 2015 | - | -$14.19M(+34.4%) | -$24.75M(+134.4%) |
Jun 2015 | - | -$10.55M(<-9900.0%) | -$10.55M(<-9900.0%) |
Mar 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
Dec 2014 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
Sep 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
Dec 2013 | -$19.95M(+5.5%) | - | - |
Dec 2013 | - | $0.00 | $0.00 |
Dec 2012 | -$18.91M | - | - |
FAQ
- What is Evolent Health, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Evolent Health, Inc.?
- What is Evolent Health, Inc. annual EBITDA year-on-year change?
- What is Evolent Health, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Evolent Health, Inc.?
- What is Evolent Health, Inc. quarterly EBITDA year-on-year change?
- What is Evolent Health, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Evolent Health, Inc.?
- What is Evolent Health, Inc. TTM EBITDA year-on-year change?
What is Evolent Health, Inc. annual EBITDA?
The current annual EBITDA of EVH is $125.50M
What is the all time high annual EBITDA for Evolent Health, Inc.?
Evolent Health, Inc. all-time high annual EBITDA is $154.20M
What is Evolent Health, Inc. annual EBITDA year-on-year change?
Over the past year, EVH annual EBITDA has changed by -$28.70M (-18.61%)
What is Evolent Health, Inc. quarterly EBITDA?
The current quarterly EBITDA of EVH is $27.25M
What is the all time high quarterly EBITDA for Evolent Health, Inc.?
Evolent Health, Inc. all-time high quarterly EBITDA is $42.08M
What is Evolent Health, Inc. quarterly EBITDA year-on-year change?
Over the past year, EVH quarterly EBITDA has changed by -$13.19M (-32.61%)
What is Evolent Health, Inc. TTM EBITDA?
The current TTM EBITDA of EVH is $101.59M
What is the all time high TTM EBITDA for Evolent Health, Inc.?
Evolent Health, Inc. all-time high TTM EBITDA is $162.20M
What is Evolent Health, Inc. TTM EBITDA year-on-year change?
Over the past year, EVH TTM EBITDA has changed by -$52.45M (-34.05%)